Providence Wealth Advisors, LLC
Position in ALDX — Aldeyra Therapeutics, Inc.
CIK 1744955
FRANKFORT, IL
Position in ALDX
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$53,250
+$11,000 QoQ
Shares Held
25,000
0.0% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#67
of 108 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Providence Wealth Advisors, LLC holds $74,250 across 2 Biotechnology names. ALDX ranks #1 (71.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALDX |
Aldeyra Therapeutics, Inc.
This page
|
25,000 | $53,250 | |
| 2 | CHRS |
Coherus Oncology, Inc.
|
15,000 | $21,000 |
All Filings in ALDX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,250 | 25,000 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $42,250 | 25,000 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $129,500 | 25,000 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $130,500 | 25,000 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $95,750 | 25,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $143,750 | 25,000 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $124,750 | 25,000 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $134,750 | 25,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $82,750 | 25,000 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $70,305 | 21,500 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,703 | 1,340 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||